Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001723561 | SCV001950725 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20981092, 24625756, 23251661, 17598838, 28508493, 28492530) |
H3Africa Consortium | RCV001528584 | SCV002014641 | benign | not specified | 2020-10-28 | criteria provided, single submitter | research | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.729, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. |
Breakthrough Genomics, |
RCV001723561 | SCV005306633 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000012817 | SCV000033057 | pathogenic | Prekallikrein deficiency | 2007-07-01 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000012817 | SCV001142341 | benign | Prekallikrein deficiency | 2020-01-06 | no assertion criteria provided | curation | NM_000892.3:c.428G>A (Ser143Asn) in the KLKB1 gene has an allele frequency of 0.738 in African subpopulation in the gnomAD database, including 43762 homozygous events. Ser143Asn was reported as N124S according to ClinVar's annotation. Katsuda et al reported three Japanese patients with plasma prekallikrein deficiency, who harbors homozygousity of Gly104Arg and Asn124Ser in 2007. Co-segregate analysis demonstrate the proband's parents were heterozygous of Gly104Arg Asn124-Ser\Gly104Arg+ (PMID: 17598838). Considering the high frequency of this variant, we classify the variant as benign. ACMG/AMP criteria applied: BA1, BS2. |
Diagnostic Laboratory, |
RCV001528584 | SCV001740539 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528584 | SCV001932945 | benign | not specified | no assertion criteria provided | clinical testing |